Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sulfonylureas
1.2.3 Meglitinides
1.2.4 Alpha-glucosidase inhibitors
1.3 Market by Application
1.3.1 Global Oral Antidiabetic Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Antidiabetic Drugs Market Perspective (2018-2029)
2.2 Oral Antidiabetic Drugs Growth Trends by Region
2.2.1 Global Oral Antidiabetic Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral Antidiabetic Drugs Historic Market Size by Region (2018-2024)
2.2.3 Oral Antidiabetic Drugs Forecasted Market Size by Region (2024-2029)
2.3 Oral Antidiabetic Drugs Market Dynamics
2.3.1 Oral Antidiabetic Drugs Industry Trends
2.3.2 Oral Antidiabetic Drugs Market Drivers
2.3.3 Oral Antidiabetic Drugs Market Challenges
2.3.4 Oral Antidiabetic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Antidiabetic Drugs Players by Revenue
3.1.1 Global Top Oral Antidiabetic Drugs Players by Revenue (2018-2024)
3.1.2 Global Oral Antidiabetic Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Oral Antidiabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Antidiabetic Drugs Revenue
3.4 Global Oral Antidiabetic Drugs Market Concentration Ratio
3.4.1 Global Oral Antidiabetic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Drugs Revenue in 2022
3.5 Oral Antidiabetic Drugs Key Players Head office and Area Served
3.6 Key Players Oral Antidiabetic Drugs Product Solution and Service
3.7 Date of Enter into Oral Antidiabetic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Antidiabetic Drugs Breakdown Data by Type
4.1 Global Oral Antidiabetic Drugs Historic Market Size by Type (2018-2024)
4.2 Global Oral Antidiabetic Drugs Forecasted Market Size by Type (2024-2029)
5 Oral Antidiabetic Drugs Breakdown Data by Application
5.1 Global Oral Antidiabetic Drugs Historic Market Size by Application (2018-2024)
5.2 Global Oral Antidiabetic Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral Antidiabetic Drugs Market Size (2018-2029)
6.2 North America Oral Antidiabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oral Antidiabetic Drugs Market Size by Country (2018-2024)
6.4 North America Oral Antidiabetic Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Antidiabetic Drugs Market Size (2018-2029)
7.2 Europe Oral Antidiabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oral Antidiabetic Drugs Market Size by Country (2018-2024)
7.4 Europe Oral Antidiabetic Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Antidiabetic Drugs Market Size (2018-2029)
8.2 Asia-Pacific Oral Antidiabetic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oral Antidiabetic Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Oral Antidiabetic Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Antidiabetic Drugs Market Size (2018-2029)
9.2 Latin America Oral Antidiabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oral Antidiabetic Drugs Market Size by Country (2018-2024)
9.4 Latin America Oral Antidiabetic Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Antidiabetic Drugs Market Size (2018-2029)
10.2 Middle East & Africa Oral Antidiabetic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oral Antidiabetic Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Oral Antidiabetic Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Oral Antidiabetic Drugs Introduction
11.1.4 Eli Lilly Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.1.5 Eli Lilly Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Oral Antidiabetic Drugs Introduction
11.2.4 Abbott Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.2.5 Abbott Recent Development
11.3 Biocon
11.3.1 Biocon Company Detail
11.3.2 Biocon Business Overview
11.3.3 Biocon Oral Antidiabetic Drugs Introduction
11.3.4 Biocon Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.3.5 Biocon Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Oral Antidiabetic Drugs Introduction
11.4.4 Sanofi Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.4.5 Sanofi Recent Development
11.5 Sunpharma
11.5.1 Sunpharma Company Detail
11.5.2 Sunpharma Business Overview
11.5.3 Sunpharma Oral Antidiabetic Drugs Introduction
11.5.4 Sunpharma Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.5.5 Sunpharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Oral Antidiabetic Drugs Introduction
11.6.4 Novartis Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.6.5 Novartis Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Detail
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Oral Antidiabetic Drugs Introduction
11.7.4 Novo Nordisk Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.7.5 Novo Nordisk Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Oral Antidiabetic Drugs Introduction
11.8.4 Merck Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Oral Antidiabetic Drugs Introduction
11.9.4 Pfizer Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.9.5 Pfizer Recent Development
11.10 Huadong Medicine Co.,Ltd.
11.10.1 Huadong Medicine Co.,Ltd. Company Detail
11.10.2 Huadong Medicine Co.,Ltd. Business Overview
11.10.3 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Introduction
11.10.4 Huadong Medicine Co.,Ltd. Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.10.5 Huadong Medicine Co.,Ltd. Recent Development
11.11 Lepu Medical
11.11.1 Lepu Medical Company Detail
11.11.2 Lepu Medical Business Overview
11.11.3 Lepu Medical Oral Antidiabetic Drugs Introduction
11.11.4 Lepu Medical Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.11.5 Lepu Medical Recent Development
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Detail
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine Oral Antidiabetic Drugs Introduction
11.12.4 Hengrui Medicine Revenue in Oral Antidiabetic Drugs Business (2018-2024)
11.12.5 Hengrui Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Antidiabetic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sulfonylureas
Table 3. Key Players of Meglitinides
Table 4. Key Players of Alpha-glucosidase inhibitors
Table 5. Global Oral Antidiabetic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Oral Antidiabetic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Oral Antidiabetic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Oral Antidiabetic Drugs Market Share by Region (2018-2024)
Table 9. Global Oral Antidiabetic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Oral Antidiabetic Drugs Market Share by Region (2024-2029)
Table 11. Oral Antidiabetic Drugs Market Trends
Table 12. Oral Antidiabetic Drugs Market Drivers
Table 13. Oral Antidiabetic Drugs Market Challenges
Table 14. Oral Antidiabetic Drugs Market Restraints
Table 15. Global Oral Antidiabetic Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Oral Antidiabetic Drugs Market Share by Players (2018-2024)
Table 17. Global Top Oral Antidiabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2022)
Table 18. Ranking of Global Top Oral Antidiabetic Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Oral Antidiabetic Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oral Antidiabetic Drugs Product Solution and Service
Table 22. Date of Enter into Oral Antidiabetic Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Antidiabetic Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Oral Antidiabetic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Oral Antidiabetic Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Oral Antidiabetic Drugs Revenue Market Share by Application (2018-2024)
Table 30. Global Oral Antidiabetic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Oral Antidiabetic Drugs Revenue Market Share by Application (2024-2029)
Table 32. North America Oral Antidiabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Oral Antidiabetic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Oral Antidiabetic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Oral Antidiabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Oral Antidiabetic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Oral Antidiabetic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Oral Antidiabetic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Oral Antidiabetic Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Oral Antidiabetic Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Oral Antidiabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Oral Antidiabetic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Oral Antidiabetic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Oral Antidiabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Oral Antidiabetic Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Oral Antidiabetic Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. Eli Lilly Company Detail
Table 48. Eli Lilly Business Overview
Table 49. Eli Lilly Oral Antidiabetic Drugs Product
Table 50. Eli Lilly Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 51. Eli Lilly Recent Development
Table 52. Abbott Company Detail
Table 53. Abbott Business Overview
Table 54. Abbott Oral Antidiabetic Drugs Product
Table 55. Abbott Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 56. Abbott Recent Development
Table 57. Biocon Company Detail
Table 58. Biocon Business Overview
Table 59. Biocon Oral Antidiabetic Drugs Product
Table 60. Biocon Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 61. Biocon Recent Development
Table 62. Sanofi Company Detail
Table 63. Sanofi Business Overview
Table 64. Sanofi Oral Antidiabetic Drugs Product
Table 65. Sanofi Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Sunpharma Company Detail
Table 68. Sunpharma Business Overview
Table 69. Sunpharma Oral Antidiabetic Drugs Product
Table 70. Sunpharma Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 71. Sunpharma Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Oral Antidiabetic Drugs Product
Table 75. Novartis Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Novo Nordisk Company Detail
Table 78. Novo Nordisk Business Overview
Table 79. Novo Nordisk Oral Antidiabetic Drugs Product
Table 80. Novo Nordisk Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 81. Novo Nordisk Recent Development
Table 82. Merck Company Detail
Table 83. Merck Business Overview
Table 84. Merck Oral Antidiabetic Drugs Product
Table 85. Merck Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Pfizer Company Detail
Table 88. Pfizer Business Overview
Table 89. Pfizer Oral Antidiabetic Drugs Product
Table 90. Pfizer Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Huadong Medicine Co.,Ltd. Company Detail
Table 93. Huadong Medicine Co.,Ltd. Business Overview
Table 94. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Product
Table 95. Huadong Medicine Co.,Ltd. Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 96. Huadong Medicine Co.,Ltd. Recent Development
Table 97. Lepu Medical Company Detail
Table 98. Lepu Medical Business Overview
Table 99. Lepu Medical Oral Antidiabetic Drugs Product
Table 100. Lepu Medical Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 101. Lepu Medical Recent Development
Table 102. Hengrui Medicine Company Detail
Table 103. Hengrui Medicine Business Overview
Table 104. Hengrui Medicine Oral Antidiabetic Drugs Product
Table 105. Hengrui Medicine Revenue in Oral Antidiabetic Drugs Business (2018-2024) & (US$ Million)
Table 106. Hengrui Medicine Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Antidiabetic Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Oral Antidiabetic Drugs Market Share by Type: 2022 VS 2029
Figure 3. Sulfonylureas Features
Figure 4. Meglitinides Features
Figure 5. Alpha-glucosidase inhibitors Features
Figure 6. Global Oral Antidiabetic Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Oral Antidiabetic Drugs Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Oral Antidiabetic Drugs Report Years Considered
Figure 12. Global Oral Antidiabetic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Oral Antidiabetic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Oral Antidiabetic Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Oral Antidiabetic Drugs Market Share by Players in 2022
Figure 16. Global Top Oral Antidiabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antidiabetic Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Oral Antidiabetic Drugs Revenue in 2022
Figure 18. North America Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Oral Antidiabetic Drugs Market Share by Country (2018-2029)
Figure 20. United States Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Oral Antidiabetic Drugs Market Share by Country (2018-2029)
Figure 24. Germany Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Oral Antidiabetic Drugs Market Share by Region (2018-2029)
Figure 32. China Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Oral Antidiabetic Drugs Market Share by Country (2018-2029)
Figure 40. Mexico Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Oral Antidiabetic Drugs Market Share by Country (2018-2029)
Figure 44. Turkey Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Oral Antidiabetic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 47. Abbott Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 48. Biocon Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 49. Sanofi Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 50. Sunpharma Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 51. Novartis Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 52. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 53. Merck Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 54. Pfizer Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 55. Huadong Medicine Co.,Ltd. Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 56. Lepu Medical Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 57. Hengrui Medicine Revenue Growth Rate in Oral Antidiabetic Drugs Business (2018-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed